<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>研发客 | wechat-feeds</title><link>http://MzAwNzMyNzQzNg.favicon.privacyhide.com/favicon.ico</link><description>《研发客》公众号由上海汐潮信息技术有限公司提供，行业资深中英文独立编辑记者创办。我们观察药物创新生态，报道临床研究与监管科学。</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 24 Feb 2021 11:45:12 +0800</pubDate><image><url>http://MzAwNzMyNzQzNg.favicon.privacyhide.com/favicon.ico</url><title>研发客 | wechat-feeds</title><link>http://MzAwNzMyNzQzNg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>罗蒂与利拉鲁肽 | 老梁说药</title><link>https://mp.weixin.qq.com/s/OVVgggmYb6VgDpMbvsx8Tw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/ic34vsx7HDaEGUtZHicuPs3w7gNa8hMORe1u2A4oRJSMAehhqqNpa5WwibZr49evzfJjgOIwJzLYPDp7oWGMAVM4w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>诺和诺德鲁肽类药领导人罗蒂学艺、悟道和创新的三重境界。]]></content:encoded><pubDate>Wed, 24 Feb 2021 00:12:24 +0800</pubDate></item><item><title>德琪医药ATG-010（Selinexor）新药上市申请获NMPA优先审评资格 | 新闻稿</title><link>https://mp.weixin.qq.com/s/SKa_c5C8F4R2Dlre1ZxWZA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/ic34vsx7HDaHDtsLv9mp9lnPf9ASwTTKGe3CWZuTekAC9bG691gIjTbesicBIu1rXRE0awSNRHhaibRMgXBKn7r4Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>让中国难治复发性多发性骨髓瘤患者早日分享新疗法。]]></content:encoded><pubDate>Wed, 24 Feb 2021 00:12:24 +0800</pubDate></item><item><title>为什么说公开药品审评信息有重要意义 | 法规观察</title><link>https://mp.weixin.qq.com/s/qrTfEIO4uvCq74OQJyqjCg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/ic34vsx7HDaEGUtZHicuPs3w7gNa8hMOReZ5xG7ib5JQnBoWFPW2ZSTGiaWGacuYZDYnmJdMZibIMT5Lzn2PAGvO3BQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>公开将提高审评机构与申请人之间沟通质量、减少沟通成本。]]></content:encoded><pubDate>Sun, 21 Feb 2021 22:24:51 +0800</pubDate></item><item><title>张彦涛：韦恩堡的两姐妹 ｜新春祝福</title><link>https://mp.weixin.qq.com/s/YKNT4zNMYin0mWwLvht0KQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/ic34vsx7HDaGMcibKhWovtPiaibWTLgPnTy0hPtcFUKm6EuEZuibAicbwYBQvLTGNqCIyohpaJJW6k8JMZIzuu8ooLsw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>他笔下的英雄是创业者的真实写照。祝大家牛年征途中所向无敌！]]></content:encoded><pubDate>Thu, 11 Feb 2021 23:24:59 +0800</pubDate></item><item><title>康威生物获得UbiVac免疫疗法癌症疫苗DPV-001大中华地区独家授权 | 新闻稿</title><link>https://mp.weixin.qq.com/s/uFofVi3l4_7Oguv3k0c7rw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/ic34vsx7HDaHrlMLQTNQSBbNUK5fG9p3jialRricQULicYLQm0WobCZ4aF4aQNbHvm2uCoff28pIBDvkfffcDtRHFg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>康威生物将获得并主导DPV-001头颈癌、乳腺癌和非小细胞肺癌等在大中华区的开发和商业化]]></content:encoded><pubDate>Thu, 11 Feb 2021 23:24:59 +0800</pubDate></item><item><title>老梁说金庸：学艺、悟道和创新 | 老梁说药</title><link>https://mp.weixin.qq.com/s/DSKfEh269cEk95zvoNOwfg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/ic34vsx7HDaGJx9PwNgEB36Jz7sAf5xbiaIxqS4zgBI7qrzQIZOQ9Rdp1YezA4XvIibJLLz0yXE6nUrw2bic1iayOtQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>新春之际，遥祝大家健康，千万别忘了留点思考的时间给自己。]]></content:encoded><pubDate>Wed, 10 Feb 2021 23:17:03 +0800</pubDate></item><item><title>CDE解读境外已上市药品进中国临床要求：鼓励早期同步 | 第一现场</title><link>https://mp.weixin.qq.com/s/qNsOieJbpSs5iCegZsEesw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/ic34vsx7HDaEiaQKv9FxrYzvWOhP2aheuLcC8jSXDh1icHJ1y6B6GGRv3HhXWsTficwDOzoCIIiay2UkaMUamW7HMQw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>“充分安全、有效性和种族因素影响相关完整证据链“，是加快国内上市进程的前提。]]></content:encoded><pubDate>Wed, 10 Feb 2021 08:32:10 +0800</pubDate></item><item><title>CDE解读Estimand：未来已来 | 第一现场</title><link>https://mp.weixin.qq.com/s/lhWG1sMigId33wntbrulNQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/ic34vsx7HDaE5BYrNhd1LoZccTtuQePstntZ0R3R46FXdMZVS6HLmNdNl24dvYVTn4ibCNk5owM3zv4gk3tqTia6w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>估计目标（Estimand）出现的合理性及其构建中临床和统计的职责。]]></content:encoded><pubDate>Wed, 10 Feb 2021 08:32:10 +0800</pubDate></item><item><title>恺思卓越人才计划——临床研究精英班（第九期）报名开始</title><link>https://mp.weixin.qq.com/s/iAUg98W1xMQiV3P4JuGyXw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/ic34vsx7HDaFmAnP57u1NrrsBUtKSgic1iav1NWPoSLvXanufnRtUK8rQc1WVEZicPqhEib69qOIKjs1SIG3SqQmuAg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>为中国临床研究和管理培育“精英人才”]]></content:encoded><pubDate>Wed, 10 Feb 2021 08:32:10 +0800</pubDate></item><item><title>CDE及专家解读肿瘤药联合用药及适应性设计｜第一现场</title><link>https://mp.weixin.qq.com/s/A8tBsd02wDk0reWzgeQaew</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/ic34vsx7HDaGJx9PwNgEB36Jz7sAf5xbiapPX0QiaUldrvI5XKHicfKXDAaxrkR82e02XJDo7t5xZ4S13uDnlMgT4w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>捷径还是陷阱？]]></content:encoded><pubDate>Mon, 08 Feb 2021 21:17:53 +0800</pubDate></item><item><title>CDE首次解读数据监察委员会指南：何时需设立DMC？ | 第一现场</title><link>https://mp.weixin.qq.com/s/pLEHEjJkcWTP_pmq88p8pA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/ic34vsx7HDaE5BYrNhd1LoZccTtuQePstntZ0R3R46FXdMZVS6HLmNdNl24dvYVTn4ibCNk5owM3zv4gk3tqTia6w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>在临床试验中，是否需要设立DMC？]]></content:encoded><pubDate>Mon, 08 Feb 2021 21:17:53 +0800</pubDate></item><item><title>创响生物和Affibody的候选药物izokibep二期临床IND获FDA批准 | 新闻稿</title><link>https://mp.weixin.qq.com/s/d2VMMgC5ekKVtw9C7JWLmA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/ic34vsx7HDaE5BYrNhd1LoZccTtuQePst3Ebicu6PA8Yo2pLbS00w0F5fBozOVBEW31QM3n9ThyyHuPoibNIviaAEw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>创响计划在不同地域、针对不同适应症在2021年获得5~8个IND。]]></content:encoded><pubDate>Mon, 08 Feb 2021 21:17:53 +0800</pubDate></item><item><title>2021年的资本市场会更好吗 | 投资观察</title><link>https://mp.weixin.qq.com/s/9rjpwHTPMFu6QnbaPd4nAg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/ic34vsx7HDaEiaQKv9FxrYzvWOhP2aheuLx7hNndApjwNJZIMPcWtnvXv5vX6Xj8rK5ic40iavicVqchdB6HLklTUKw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>花旗环球金融分析师认为，2021年中国医药行业将欣欣向荣地复苏。]]></content:encoded><pubDate>Sun, 07 Feb 2021 22:46:09 +0800</pubDate></item><item><title>天境生物公布差异化的CD73抗体Uliledlimab的全球多项临床进展 | 新闻稿</title><link>https://mp.weixin.qq.com/s/ZzfYe4mpV3umyIPfIUhE9g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/ic34vsx7HDaHsHeBa1BC2ywMjL1dM95Fu3YCb3zfA53Yiblpkay6EPIJQs5Axg6qQlK1UvQVia9e7T8tLlcNMB5Sg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Uliledlimab通过抑制腺苷生成有效解除肿瘤微环境的免疫抑制以提高全身及肿瘤局部免疫反应。]]></content:encoded><pubDate>Sun, 07 Feb 2021 09:22:12 +0800</pubDate></item><item><title>德益阳光“同病第一”抗病毒新药PSP001美国IND申报获批 | 新闻稿</title><link>https://mp.weixin.qq.com/s/89yq8gwEhX1Pf_x_IQdtHQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/ic34vsx7HDaEiaQKv9FxrYzvWOhP2aheuLAMh89X2iaibsVjMlJ1tyibgnzkkAznMXLepGZx98p9ZNicR6Sy4XQyFMPw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>计划很快提交多个全球同病第一新药的临床申请]]></content:encoded><pubDate>Fri, 05 Feb 2021 21:52:25 +0800</pubDate></item><item><title>3类化药研发将重焕生机 | 第一现场</title><link>https://mp.weixin.qq.com/s/qUS0RbHw0JAk-0x5yx75VA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/ic34vsx7HDaF6kPEcPPhl3Hib4bOlMze0g4oA1FGWNcib0ZpZMsOeiaxMQdrWbvMicpAp2mQGWvs4UNFuWF4CKsU5eQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>新法规对3类化药临床研究和注册路径清晰明确，申请人要具体案例具体分析。]]></content:encoded><pubDate>Thu, 04 Feb 2021 21:49:42 +0800</pubDate></item><item><title>邀请函 | 临床开发与创新合作论坛 2021</title><link>https://mp.weixin.qq.com/s/EMAdNlvFtT_1gzaAQg-wig</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/ic34vsx7HDaEU8tqNv1aqwAjkkFzCL5U8PVy8sKzoLvMbgEdfBmWJEK0t4RAwfnicpgY8NR9JVXGDgyWugiarmS2A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>CDIF2021旨在建立与加强行业沟通, 在精准医疗的大背景下, 促进药物的高效与高质量临床研究。]]></content:encoded><pubDate>Thu, 04 Feb 2021 21:49:42 +0800</pubDate></item></channel></rss>